window.lintrk('track', { conversion_id: 15481201 });

DrugCoat

DRUGCOAT

Excellence in Pharma Polymer

US-DMF available

DRUGCOAT polymer range of products has excellent potential as versatile & unique in different applications in NDDS including customized and newer applications. Therefore, the pharma industry has now started looking for newer coating materials and is in a process of shifting from conventional coating materials to NEXTGEN polymer i.e. Methacrylic acid copolymers.

Types/Series

The best range of methacrylate co-polymer for enteric coating, protective coating, taste masking, and sustained release formulations are offered by Vikram Thermo (India) Limited under the brand name DRUGCOAT®.

DRUGCOAT L & S Series ENTERIC COATING FORMULATION

  • DRUGCOAT L 30D
  • DRUGCOAT L 100-55
  • DRUGCOAT L 100-55D
  • DRUGCOAT L 100
  • DRUGCOAT L 12.5
  • DRUGCOAT S 100
  • DRUGCOAT S 12.5
  • DRUGCOAT FS 30D

DRUGCOAT E Series TASTE MASKING AND PROTECTIVE COATING

  • DRUGCOAT E 100
  • DRUGCOAT E PO
  • DRUGCOAT E 12.5

DRUGCOAT RL/RS & NE Series SUSTAINED RELEASE FORMULATION

  • DRUGCOAT RL 100
  • DRUGCOAT RL PO
  • DRUGCOAT RL 12.5
  • DRUGCOAT RS 100
  • DRUGCOAT RS PO
  • DRUGCOAT RS 12.5
  • DRUGCOAT NE 30D

DRUGCOAT L & S Series ENTERIC COATING FORMULATION

DRUGCOAT SERIES MONOGRAPHS PHYSICAL FORM DISSOLUTION PROPERTIES
AQUEOUS ENTERIC COATING
DRUGCOAT L30D USP/NF: Methacrylic Acid And Ethyl Acrylate Copolymer Dispersion
Ph. Eur.: Methacrylic Acid-Ethyl Acrylate Copolymer(1:1) Dispersion 30%
Aqueous Dispersion 30% Dissolve above pH 5.5
DRUGCOAT L 100-55 USP/NF: Methacrylic Acid And Ethyl Acrylate Copolymer
Ph. Eur.: Methacrylic Acid- Ethyl Acrylate Copolymer (1:1) Type A
Powder
DRUGCOAT L 100-55D USP/NF: Partially–Neutralized Methacrylic Acid & Ethyl Acrylate Copolymer
Ph. Eur.: Methacrylic Acid- Ethyl Acrylate Copolymer (1:1) Type B
Powder
NON AQUEOUS ENTERIC COATING
DRUGCOAT L 100 USP/NF: Methacrylic Acid And Methyl Methacrylate Copolymer (1:1)
Ph. Eur.: Methacrylic Acid – Methyl Methacrylate Copolymer (1:1)
Powder Dissolve above pH 6.0
DRUGCOAT L 12.5 Organic Solution 12.5%
COLON TARGETED ENTERIC COATING
DRUGCOAT S 100 USP/NF: Methacrylic Acid And Methyl Methacrylate Copolymer (1:2)
Ph. Eur.: Methacrylic Acid – Methyl Methacrylate Copolymer (1:2)
Powder Dissolve above pH 7.0
DRUGCOAT S 12.5 Organic Solution 12.5%
DRUGCOAT FS 30D Aqueous Dispersion 30% Dissolve above pH 7.0

DRUGCOAT E Series TASTE MASKING AND PROTECTIVE COATING

DRUGCOAT SERIES MONOGRAPHS PHYSICAL FORM DISSOLUTION PROPERTIES
DRUGCOAT E 100 USP/NF: Amino Methacrylate Copolymer
Ph. Eur.: Basic Butylated Methacrylate Copolymer
Granules Dissolve up to pH 5.0
Soluble in Gastric Fluid
DRUGCOAT E PO Powder
DRUGCOAT E 12.5 Organic Solution 12.5%

DRUGCOAT RL/RS & NE Series SUSTAINED RELEASE FORMULATION

DRUGCOAT SERIES MONOGRAPHS PHYSICAL FORM DISSOLUTION PROPERTIES
DRUGCOAT RL 100 USP/NF: Ammonio Methacrylate Copolymer, Type A
Ph. Eur.: Ammonio Methacrylate Copolymer, Type A
Granules pH-independent swelling
DRUGCOAT RL PO Powder
DRUGCOAT RL 12.5 Organic Solution 12.5%
DRUGCOAT RS 100 USP/NF: Ammonio Methacrylate Copolymer, Type B
Ph. Eur.: Ammonio Methacrylate Copolymer, Type B
Granules
DRUGCOAT RS PO Powder
DRUGCOAT RS 12.5 Organic Solution 12.5%
DRUGCOAT NE 30D USP/NF: Ethyl Acrylate And Methyl Methacrylate Copolymer Dispersion
Ph. Eur.: Polyacrylate Dispersion 30%
Aqueous Dispersion 30%

Why choose DrugCoat?

DrugCoat® offers a flexible and modern polymer coating platform based on methacrylic copolymers, designed to support multiple drug delivery strategies, enteric protection, taste masking, and sustained release. These coatings help shield both the drug and stomach lining from harsh acidity, improve moisture and taste stability, and enable controlled or targeted release, reducing dosing frequency and side effects while enhancing patient compliance.

FAQs

DRUGCOAT is a versatile coating system by Vikram thermo pharma that improves stability, taste masking, and release control in drug formulations. It’s built on advanced polymethyl acrylate technology for reliable performance.

Yes, DRUGCOAT supports colon-specific delivery by using pH-sensitive polymethyl acrylate coatings that dissolve only in targeted intestinal environments. Thermo Pharma’s research ensures precise release control.

Methacrylic copolymers like polymethyl acrylate offer pH-dependent solubility, sustained release, and improved drug stability. Thermo Pharma leverages these polymers for effective therapeutic outcomes.

DRUGCOAT is engineered for compatibility with both aqueous and non-aqueous systems, making it ideal for diverse applications. Polymethyl acrylate plays a key role in this flexibility.

All DRUGCOAT products follow global regulatory norms including USP, EP, and JP standards. Thermo Pharma ensures quality by using high-grade polymethyl acrylate-based polymers in its formulations.

By Application

DRUGCOAT L & S Series

  • pH-Dependent drug release
  • Protection of API from gastric fluid
  • Protection of gastric mucosa from API
  • Increase storage stability
  • GI and colon targeting
  • Insulate hygroscopic cores
  • Maintain the better stability of phthalate group coating agent
  • Enteric coating of API formulations

DRUGCOAT E Series

  • pH Dependent Drug release
  • Protection of API from environmental factors
  • Improves patient compliance
  • Lowest WVTR in its Class
  • Moisture Protection
  • Higher stability
  • Taste and Odor Masking
  • Improve storage stability of Sensitive API’s

DRUGCOAT RL/RS & NE Series

  • For Sustain Release of API’s.
  • Customized release profiles
  • Prolongation of effective plasma level
  • Reduction of total dose
  • Reduce risk of dose dumping
  • Reduce toxicological effects of API’s
  • Reduction of Administration frequency
  • Increase patient compliance

Let’s explore opportunities

Our company revolves around giving maximum to the two pillars that lay the foundation for our business: People and Product. Through constant R&D and innovation, the company plans to build a better future without compromising the quality and safety to reach a higher level of excellence in healthcare facilities.

Let’s create opportunities together
hand-shake-1(1)